Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Nanobody

  • You have access
    Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single Domain Antibody Fragment
    Yutian Feng, Rebecca Meshaw, Xiao-guang Zhao, Stephen A. Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264071; DOI: https://doi.org/10.2967/jnumed.122.264071
  • Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Open Access
    Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
    Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, Thomas Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt and Karine Breckpot
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1638-1644; DOI: https://doi.org/10.2967/jnumed.120.258871
  • You have access
    Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology
    Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Sörensen, Anna Orlova, Marleen Keyaerts and Vladimir Tolmachev
    Journal of Nuclear Medicine June 1, 2018, 59 (6) 885-891; DOI: https://doi.org/10.2967/jnumed.117.199901
  • You have access
    Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of 89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
    Frank J. Warnders, Anton G.T. Terwisscha van Scheltinga, Christine Knuehl, Maarten van Roy, Erik F.J. de Vries, Jos G.W. Kosterink, Elisabeth G.E. de Vries and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine August 1, 2017, 58 (8) 1210-1215; DOI: https://doi.org/10.2967/jnumed.116.181586
  • You have access
    Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET
    Ganesan Vaidyanathan, Darryl McDougald, Jaeyeon Choi, Eftychia Koumarianou, Douglas Weitzel, Takuya Osada, H. Kim Lyerly and Michael R. Zalutsky
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 967-973; DOI: https://doi.org/10.2967/jnumed.115.171306
  • You have access
    Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
    Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois P. Duhoux, Thierry Gevaert, Philippe Simon, Denis Schallier, Christel Fontaine, Ilse Vaneycken, Christian Vanhove, Jacques De Greve, Jan Lamote, Vicky Caveliers and Tony Lahoutte
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 27-33; DOI: https://doi.org/10.2967/jnumed.115.162024
  • You have access
    A Novel 111In-Labeled Anti–Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer
    Kristell L.S. Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, Sander Hoeben, Gerben A. Koning, Otto C. Boerman, Marion de Jong and Wytske M. van Weerden
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 1094-1099; DOI: https://doi.org/10.2967/jnumed.115.156729
  • You have access
    Molecular Imaging with Macrophage CRIg-Targeting Nanobodies for Early and Preclinical Diagnosis in a Mouse Model of Rheumatoid Arthritis
    Fang Zheng, Stéphanie Put, Luc Bouwens, Tony Lahoutte, Patrick Matthys, Serge Muyldermans, Patrick De Baetselier, Nick Devoogdt, Geert Raes and Steve Schoonooghe
    Journal of Nuclear Medicine May 1, 2014, 55 (5) 824-829; DOI: https://doi.org/10.2967/jnumed.113.130617
  • You have access
    Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling
    Marek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, Hilde Revets, Nick Devoogdt, Tony Lahoutte, H. Kim Lyerly and Michael R. Zalutsky
    Journal of Nuclear Medicine April 1, 2014, 55 (4) 650-656; DOI: https://doi.org/10.2967/jnumed.113.127100
  • You have access
    SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis
    Stéphanie Put, Steve Schoonooghe, Nick Devoogdt, Evelien Schurgers, Anneleen Avau, Tania Mitera, Matthias D’Huyvetter, Patrick De Baetselier, Geert Raes, Tony Lahoutte and Patrick Matthys
    Journal of Nuclear Medicine May 1, 2013, 54 (5) 807-814; DOI: https://doi.org/10.2967/jnumed.112.111781
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire